Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Curr Opin Pediatr. 2017 Oct;29(5):534–540. doi: 10.1097/MOP.0000000000000533

Table 1.

Variant classification Criteria

Pathogenic Predicted null variant in gene where loss of function is known disease mechanism; de novo variant; absent in population databases or MAF very low; co-segregation in multiple families; computational predictions support deleterious effect; functional data support deleterious effect

Likely Pathogenic Criteria similar to pathogenic but with less supporting evidence such as fewer available families for co-segregation data, contradictory computational predictions or weaker functional data

Variant Uncertain Significance Very low population frequency or absent from databases but lacking co-segregation, computational, and/or functional evidence for pathogenicity

Likely Benign Allele frequency greater than expected for disease incidence; allele identified in young, healthy individuals; no effect in functional assays; lack of segregation in family members; and/or mutation type not consistent with known disease mechanism

Benign MAF >5% in ExAC or ESP OR 2 or more of the likely benign criteria

ESP, Exome Sequencing Project; ExAC, Exome Aggregation Consortium; MAF, minor allele frequency. For detailed criteria, see Richards et al. (32)